Seeking Alpha

J&J accepts Carlyle's $4.15B bid for diagnostics unit

  • Johnson & Johnson (JNJ) has accepted Carlyle's (CG) $4.15B binding offer for J&J's Ortho-Clinical Diagnostics (OCD) business.
  • J&J accepted the proposal, which the private-equity firm made in January, after consultation with the relevant works councils and trade unions.
  • J&J expects the deal to close toward the middle of the year. (PR)
Comments (3)
  • hman487
    , contributor
    Comment (1) | Send Message
     
    Defining their true market area of emphasis while eliminating those areas which don't fit into their future image of JNJ........remodeling and renovation of a very large business entity into a scaled down super functioning business model to deal with the next twenty years of life science and pharma......
    31 Mar, 09:16 AM Reply Like
  • biochemist
    , contributor
    Comments (391) | Send Message
     
    Interesting move to sell off Ortho. I guess the margins were not great enough in selling diagnostic kits.
    31 Mar, 11:17 AM Reply Like
  • Eric Chemist
    , contributor
    Comments (6) | Send Message
     
    $4Billion to put towards acquisitions to help their pipeline.
    4 Apr, 03:23 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector